Skip to main content
Equibles

Driehaus Capital Management LLC

Position in COAG — Hemab Therapeutics Holdings, Inc.

CIK 938206 Chicago, IL
Back to COAG Full portfolio

Position in COAG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,291,003
New position
Shares Held
715,791
first reported quarter
Ownership
1.53%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#12
of 56 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 85% Shared 0% None 15%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. COAG ranks #30 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5
6,463,551 $241,866,078
6
1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in COAG

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $26,291,003 715,791